Health status and physical activity after discharge due to pleural effusion

I. Torres Sanchez (Granada, Spain), J. Rodríguez-Torres (Granada, Spain), J. Valenzuela-Canovaca (Granada, Spain), I. Cabrera-Martos (Granada, Spain), R. Romero-Fernández (Granada, Spain), M. Valenza (Granada, Spain)

Source: International Congress 2019 – Oxygen supplementation, noninvasive ventilation and mobility aspects of patients with impaired respiration

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Torres Sanchez (Granada, Spain), J. Rodríguez-Torres (Granada, Spain), J. Valenzuela-Canovaca (Granada, Spain), I. Cabrera-Martos (Granada, Spain), R. Romero-Fernández (Granada, Spain), M. Valenza (Granada, Spain). Health status and physical activity after discharge due to pleural effusion. 1234

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The effect of a pleural diseases clinic on pleural effusion admission rates
Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions
Year: 2012


Medical pleuroscoy, role in undiagnosed pleural effusion and therapy for pneumothorax and recurrent pleural effusion
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013


Management of effusion in low performance status patients
Source: ERS Skills Course 2015
Year: 2015

A Study of physical activity and sedentary behaviour in patients with malignant pleural effusion undergoing therapeutic interventions: ASPIRE
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020




Diagnostic implications of telomerase activity in pleural effusions
Source: Eur Respir J 2003; 22: 422-426
Year: 2003



Treatment of children with pleural effusion
Source: Eur Respir J 2007; 30: Suppl. 51, 243s
Year: 2007

Quality indicators in pleural pathology
Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs
Year: 2018

Lymphocytic pleural effusion. Can ADA levels in pleural fluid exclude malignancy?
Source: Eur Respir J 2006; 28: Suppl. 50, 783s
Year: 2006

A Dutch web-survey on management of malignant pleural effusions
Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions
Year: 2011


A patient with persisting bilateral pleural effusion
Source: Annual Congress 2006 - Clinical Grand Round: an interactive session
Year: 2006

Influence of psychological distress on symptom burden of patients admitted by malignant pleural effusion
Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside
Year: 2020


Impact of sarcopenia in long-term symptoms in patients with malignant pleural effusion.
Source: Virtual Congress 2021 – Accurate diagnosis and prediction of malignant pleural disease
Year: 2021


Is the size of pleural effusion important in the study of patients whose first tumor manifestation is a pleural effusion?
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017


Diagnostic approach in a patient with pleural effusion
Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=131
Year: 2002

Epidemiology of pleural effusion
Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=146
Year: 2002

Management of malignant pleural effusion
Source: Eur Respir J 2001; 18: Suppl. 33, 397s
Year: 2001

Management of unilateral pleural effusion in a DGH setting
Source: Annual Congress 2009 - Pleural diseases
Year: 2009